Skip to content

Study of Testing Response in Patients with Type 2 Diabetes

Study of Testing Response in Patients with Type 2 Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN87372235
Enrollment
300
Registered
2005-10-06
Start date
2002-01-01
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Nutritional, Metabolic, Endocrine Diabetes

Interventions

We conducted a randomised controlled trial to evaluate the clinical and behavioural impact of simply providing free SMBG supplies to patients with type 2 diabetes, versus a common health care policy o

Sponsors

Institute of Health Economics (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: To be included in the study, patients must: 1. Have had type 2 diabetes of at least one year duration 2. Be 30 years of age or older 3. Not be on insulin Patients that controlled their diabetes by diet alone were eligible if they met the above inclusion criteria.

Exclusion criteria

Exclusion criteria: We excluded pregnant patients and those with gestational diabetes, as well as patients with private insurance coverage for SMBG supplies.

Design outcomes

Primary

MeasureTime frame
Change in HbA1c over 6 months.

Secondary

MeasureTime frame
Our secondary outcome evaluated SMBG behaviours using the Summary of Diabetes Self-Care Activities (SDSCA). In addition, patients completed a self-administered survey at baseline and 6 month follow-up. The survey contained demographic and self-reported clinical information regarding duration of diabetes, comorbidities and complications due to diabetes, and diabetes education experience. Self-reported physical and mental health status was captured in the RAND-12.

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026